14 March 2023
MYCELX TECHNOLOGIES CORPORATION (AIM: MYX)
Closure of Restricted Stock Line
MYCELX Technologies Corporation ("MYCELX" or the "Company"), the clean water and clean air technology company, confirms the closure of its restricted line of stock will take effect at 8.00 a.m. on 22 March 2023.
Application has been made to the London Stock Exchange for the transfer of an additional 3,539,273 common shares of $0.25 each ("Common Shares") (the "Additional Shares") from the Company's restricted line of stock with the ticker MYXR (identified under ISIN USU624551235) (the "Restricted Line") to the Company's unrestricted line of stock with the ticker MYX (identified under ISIN US62847T2024) (the "Unrestricted Line").
The Additional Shares are constituted of 3,539,273 Common Shares which have been transferred upon expiry of the restricted period under Regulation S of the US Securities Act of 1933.
Trading in the Company's Restricted Line will cease at 8.00 a.m. on 22 March 2023 and all Common Shares currently trading on the Restricted Line will from then on continue to trade on the Unrestricted Line. Certificated holders will also be issued a replacement share certificate, representing their new holding in unrestricted shares.
The Company's issued share capital consists of 22,983,023 Common Shares with no Common Shares held in treasury. Therefore, the total number of voting rights in the Company is 22,983,023 which may be used by shareholders as the denominator for the calculations by which they determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.
From 22 March 2023, all of the 22,983,023 Common Shares will be admitted to trading on the Unrestricted Line.
For further information, please contact:
MYCELX Technologies Corporation Connie Mixon, CEO Kim Slayton, CFO
|
Tel: +1 888 306 6843 |
Canaccord Genuity Limited (Nomad and Sole Broker) Henry Fitzgerald-O'Connor Gordon Hamilton
|
Tel: +44 20 7523 8000 |
Celicourt Communications (Financial PR) Mark Antelme Jimmy Lea |
Tel: +44 20 8434 2754 |
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.